ArticleCureus2025
Acute Tubular Necrosis Following Renal Transplantation: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute tubular necrosis (ATN) remains one of the most frequent causes of delayed graft function (DGF) following renal transplantation, particularly in the early postoperative period. It is commonly associated with ischemia-reperfusion injury, prolonged cold or warm ischemia time, donor-related hemodynamic instability, and the nephrotoxic effects of calcineurin inhibitors (CNI) such as cyclosporine. ATN contributes significantly to early post-transplant morbidity, impacts long-term graft survival, and poses diagnostic challenges due to its clinical overlap with acute rejection. Cyclosporine-induced nephrotoxicity can result in severe tubular injury, leading to ATN, particularly in the early post-transplant period. Despite its efficacy in preventing graft rejection, cyclosporine's toxic effects on the renal vasculature and tubular cells can exacerbate ischemia-reperfusion injury, prolong graft dysfunction, and increase the need for dialysis. Here, we report a case of ATN following renal transplantation in a patient who was on cyclosporine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.